(02) 9850 4000
GlyTherix
  • Home
  • Company
    • Financial Statements
  • Product Pipeline
  • For Investors
  • News
  • Contact Us
Select Page
Protected: ‘Cancer hasn’t gone away’

Protected: ‘Cancer hasn’t gone away’

by GlyTherix | Jul 29, 2022

Password Protected

To view this protected post, enter the password below:

GlyTherix Awarded $3 Million Co-operative Research Centre Project Grant

GlyTherix Awarded $3 Million Co-operative Research Centre Project Grant

by GlyTherix | Jul 16, 2020

16th July 2020: Sydney • Project boasts a dream team of world class partners across antibody manufacturing and clinical trials • Grant will support development of national capability in manufacture and distribution of radioimmuno-oncology drugs • GlyTherix’s...
Four New Peer Reviewed Papers Underline the Strength of the GlyTherix  Technology

Four New Peer Reviewed Papers Underline the Strength of the GlyTherix Technology

by GlyTherix | May 19, 2020

Tuesday 19th May 2020: Sydney GlyTherix Ltd (GlyTherix) is pleased to report publication of four new peer reviewed papers covering both basic science as well as pre-clinical studies around our proprietary novel target, Glypican-1 and our lead antibody to this target,...

ENQUIRIES

Address
Suite 2, Ground Floor, 75 Talavera Road, Macquarie Park, NSW 2113, Australia

Phone
Intl: +612 9850 4000
Aust: 02 9850 4000
(Compare your time zone with Sydney here)

Recent Posts

  • Protected: ‘Cancer hasn’t gone away’
  • High-Yield GMP-Compliant Primary Cell Bank Established for Miltuximab®
  • GlyTherix is a partner in ARC Hub for Advanced Manufacture of Targeted Radiopharmaceuticals

RECENT POSTS

  • Protected: ‘Cancer hasn’t gone away’
  • High-Yield GMP-Compliant Primary Cell Bank Established for Miltuximab®
  • GlyTherix is a partner in ARC Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
  • GlyTherix and GEMINI Collaborate on Esophageal Cancer

ENQUIRIES

Address
Suite 2, Ground Floor, 75 Talavera Road, Macquarie Park, NSW 2113, Australia

Phone
Intl: +612 9850 4000
Aust: 02 9850 4000
(Compare your time zone with Sydney here)

MORE INFO

FOR SHAREHOLDERS:
Shareholder Communications Options

Would you like to talk with Glytherix about:

  • Investing in us?
  • Partnering with us?
  • Media events?
  • Some feedback?
  • Home
  • News
  • Terms of Use
  • Privacy Policy
  • Contact Us

COPYRIGHT 2022 | GLYTHERIX - ALL RIGHTS RESERVED